Clinical Trial

Study on the Detection of Pleuropulmonary Manifestations in Rheumatoid Arthritis

Study acronym: REASSESS
Recruiting
View on ClinicalTrials.gov →
Summary
The aim of the study is to develop a standardized, risk-adapted screening protocol for detecting pleuropulmonary manifestations in patients with rheumatoid arthritis. To assess the risk of these manifestations, a comprehensive range of functional and clinical evaluations will be performed and correlated with structural lung assessments using computed tomography (CT).
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-05-09.
Trial Details
NCT Number NCT06965322
Lead Sponsor Medical University Innsbruck
Conditions Rheumatic Arthritis, Interstitial Lung Disease in Patients With Rheumatoid Arthritis
Enrollment 800 participants
Start Date 2024-11-11
Primary Completion 2028-05-30 (estimated)
Study Completion 2029-09-30 (estimated)
Updated on ClinicalTrials.gov 2025-12-02